Legislation & regulation

AAHA_Newstat_300.png
  • March 27, 2012

    Debate over emotional damages continues in North Carolina

    The debate over emotional damages for pets continues in North Carolina. The North Carolina Appeals Court recently upheld the decision of the North Carolina Industrial Commission, which concluded that courts have not recognized intrinsic value as a measure for damages for the loss of an animal. The plaintiffs, Nancy and Herbert Shera, filed for the wrongful death of their 12-year-old Jack Russell Terrier, Laci. Diagnosed with liver cancer in 2003, Laci was treated at the Veterinary Specialty Hospital (VSH) in Cary, North Carolina, where staff successfully removed the tumor. By late 2003, Laci’s cancer was determined to be in remission. In 2007, Laci was re-admitted to the VSH for multi-systemic organ disease and multiple life-threatening symptoms, including a severe form of pancreatitis, ascites, electrolyte derangements, and other serious veterinary issues. The canine exhibited symptoms of poor appetite, vomiting, and difficulty with urination.
  • February 21, 2012

    Arizona bill would aid animals in suspected cruelty

    A new bill in the Arizona State Legislature would allow law enforcement officials to enter properties to seize an animal if there is probably cause to believe that the animal is suffering from cruelty or abandonment.
  • January 10, 2012

    FDA seeks veterinarian input on drug-approval process

    Recent drug shortages in both the veterinary and human health worlds have forced veterinarians to fall back on drugs unapproved by the U.S. Food and Drug Administration (FDA) or face leaving their patients untreated.
  • November 22, 2011

    Bayer, Elanco settle false advertising suit

    Bayer and Elanco have agreed to a settlement over a false advertising suit Bayer filed against Elanco in May 2011.   Bayer Animal Health filed the suit against Elanco, objecting to an April letter Elanco sent to veterinarians about the flea and tick marketplace. Bayer alleged that in the letter, Elanco released false advertising and created unfair competition that wrongfully misled veterinarians and distributors. Bayer’s Animal Health Division manufactures and sells pet medicines such as Advantage II, K9 Advantix II and Advantage Multi products for flea, tick and heartworm prevention. Elanco is a division of Eli Lilly and Company, a global pharmaceutical corporation. Eli Lilly’s Elanco Companion Animal Health division produces pet medicines for flea and heartworm prevention such as Comfortis, Assurity and Trifexis.
  • November 22, 2011

    FDA urges caution with chicken jerky treats

    The U.S. Food and Drug Administration (FDA) is seeing an increase in the number of complaints about dog illnesses associated with consumption of chicken jerky products imported from China. In a warning posted Nov. 18, the FDA warns consumers that chicken jerky products for dogs in chicken tenders, strips or treats, could cause illnesses in dogs. In September 2007, the FDA issued a cautionary warning about chicken jerky products followed by a Preliminary Animal Health Notification in December 2008. The FDA reports that the number of complaints dropped off near the end of 2009 and continued to decrease throughout 2010. In the last 12 months, however, the FDA says it is seeing complaints rise once again.
  • November 8, 2011

    Drug shortages: The new reality for veterinarians

    President Obama’s announcement Oct. 31 about his efforts to relieve drug shortages in the United States was a step in the right direction, but veterinarians are saying more needs to be done if medical communities are to get back on track with prescription drugs. According to the New York Times, Obama’s order will instruct the Food and Drug Administration to do three things: broaden reporting of potential shortages of certain prescription drugs; speed reviews of applications to begin or alter production of these drugs; and provide more information to the Justice Department about possible instances of collusion or price gouging. For veterinarians, however, prescription drug shortages have been a growing problem over the years that is not likely to go away any time soon. A growing issue Margo Karriker, clinical pharmacy specialist at the University of California Davis, says drug shortages are becoming more and more common for veterinarians. "Every single day we’re seeing something that we use becoming unavailable," Karriker says. "A lot of it is around the fact that so many of the drugs we use are human-labeled drugs."
  • September 6, 2011

    NVAP renewal deadline set for Oct. 1

    Veterinarians will have until Oct. 1 to renew their accreditation with the National Veterinary Accreditation Program (NVAP). The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) announced earlier this year that currently accredited veterinarians may continue to perform accredited duties "until further notice." On Aug. 23, APHIS said that it is almost finished processing the participation elections of the more than 50,000 currently accredited veterinarians. That fact has allowed the agency to specify the Oct. 1 deadline for accreditation renewal.  
  • July 4, 2011

    AAHA opposes HR 1406

    In response to the introduction of the "Fairness to Pet Owners Act of 2011," AAHA has issued a statement in opposition to the bill.
  • June 20, 2011

    EPA to ban some rodenticides

    The U.S. Environmental Protection Agency is preparing to ban the sale of certain rodenticides to the general public, a move which could help prevent one of the most frequent causes of pet poisoning.   In addition to banning the most toxic anticoagulant rodenticides (brodifacoum, bromadiolone, difethialone and difenacoum), the agency also plans to stop the sale of most loose bait and pellet-form rodenticides to cut down on accidental poisonings of children and pets.
  • May 22, 2011

    Nevada considers drug recycling

    The Nevada state Senate is considering a bill that would allow veterinarians and veterinary care facilities to accept open and unopened prescription medication and re-issue them to clients who cant afford them.